Credo (CRDO) CEO Reports 68,016-Share Sale; 10b5-1 Plan Used
Rhea-AI Filing Summary
Credo Technology Group Holding Ltd (CRDO) insider sale summary: On 09/16/2025 William J. Brennan, who is President, CEO and a director, reported multiple open-market sales totaling 68,016 ordinary shares. The sales were executed in tranches at weighted-average prices ranging from about $160.80 to $167.78 per share and were effected under a Rule 10b5-1 trading plan adopted April 15, 2025. After the transactions, the reporting person directly owned 369,173 shares and indirectly (through The Brennan Family Trust dated 09/06/2002) had beneficial ownership of 1,992,502 shares, with the reporting person disclaiming beneficial ownership except to the extent of pecuniary interest.
Positive
- Sales executed under a Rule 10b5-1 plan, indicating transactions were pre-arranged
- Detailed price ranges and weighted-average prices provided for each tranche
- Reporting retains substantial ongoing ownership (approximately 2.36 million shares combined)
Negative
- Insider sold 68,016 shares on 09/16/2025, which is a notable single-day disposition
- Significant portion of holdings placed into market across multiple tranches, which could be interpreted negatively by some investors
Insights
TL;DR: Insider sold 68,016 shares under a pre-established 10b5-1 plan; holdings remain substantial, suggesting routine liquidity rather than full exit.
The disclosed trades were executed in multiple tranches on 09/16/2025 at weighted-average prices spanning roughly $160.80 to $167.78. Total shares sold equal 68,016, which reduced direct and indirect holdings but left the reporting person with material exposure: approximately 2.36 million shares combined between direct and trust holdings. The use of a 10b5-1 plan and the detailed price ranges provided in the explanations are consistent with pre-planned, rule-compliant disposition rather than opportunistic intra-period selling. From a quantitative standpoint, the sales represent a modest percentage of total reported holdings and therefore are unlikely, by themselves, to be materially dilutive or indicate a change in control.
TL;DR: Disclosure is thorough and includes 10b5-1 plan citation and price ranges; beneficial ownership disclaimers are stated.
The Form 4 clearly states the transactions were effected pursuant to a Rule 10b5-1 trading plan adopted April 15, 2025, and provides weighted-average prices and price ranges for each tranche. The Reporting Person disclaims beneficial ownership of the trust-held shares except for pecuniary interest, which is properly noted. Signature by an attorney-in-fact is included. These elements meet standard corporate governance disclosure expectations for insider dispositions. No flags for incomplete procedural disclosure are present in the filing itself.
FAQ
What did William J. Brennan report on Form 4 for CRDO?
How many shares did the reporting person own after the transactions?
At what prices were the CRDO shares sold?
Were the sales discretionary or pre-planned?
Does the reporting person claim beneficial ownership of all trust shares?